14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.500 $0.720 Tuesday, 23rd Apr 2024 ADXS stock ended at $0.540. This is 5.59% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 5.47% from a day low at $0.512 to a day high of $0.540.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Aug 16, 2021 $0.430 $0.430 $0.390 $0.398 3 275 577
Aug 13, 2021 $0.430 $0.435 $0.420 $0.420 1 646 903
Aug 12, 2021 $0.439 $0.440 $0.426 $0.430 1 831 933
Aug 11, 2021 $0.444 $0.452 $0.431 $0.437 1 878 270
Aug 10, 2021 $0.457 $0.463 $0.440 $0.442 2 090 578
Aug 09, 2021 $0.437 $0.448 $0.433 $0.446 1 998 593
Aug 06, 2021 $0.440 $0.446 $0.430 $0.431 1 592 924
Aug 05, 2021 $0.426 $0.456 $0.424 $0.436 2 751 709
Aug 04, 2021 $0.412 $0.440 $0.412 $0.430 4 083 617
Aug 03, 2021 $0.439 $0.441 $0.416 $0.429 2 365 995
Aug 02, 2021 $0.420 $0.443 $0.415 $0.440 2 937 296
Jul 30, 2021 $0.413 $0.426 $0.410 $0.410 1 853 309
Jul 29, 2021 $0.435 $0.440 $0.412 $0.412 1 823 991
Jul 28, 2021 $0.410 $0.430 $0.405 $0.430 2 552 781
Jul 27, 2021 $0.409 $0.415 $0.396 $0.412 2 803 803
Jul 26, 2021 $0.413 $0.425 $0.406 $0.408 3 311 360
Jul 23, 2021 $0.435 $0.437 $0.412 $0.420 3 303 880
Jul 22, 2021 $0.448 $0.448 $0.430 $0.434 2 540 012
Jul 21, 2021 $0.437 $0.450 $0.437 $0.445 2 709 116
Jul 20, 2021 $0.440 $0.450 $0.430 $0.442 3 345 406
Jul 19, 2021 $0.425 $0.440 $0.420 $0.435 3 708 202
Jul 16, 2021 $0.454 $0.464 $0.435 $0.441 4 430 804
Jul 15, 2021 $0.446 $0.460 $0.425 $0.449 6 543 643
Jul 14, 2021 $0.465 $0.470 $0.441 $0.441 5 231 097
Jul 13, 2021 $0.480 $0.483 $0.447 $0.453 7 703 016
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT